4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-26-032866
Options or other derivatives
- Chief Science Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
PICKER DONALD H · Chief Science Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-15 | Grant or award : show line 1 in the form Stock Options (right to buy) | +250,000 | 789,595 | D |
Loading xslF345X06/rdgdoc.xml…